“…Consequently, glucocorticoids have been shown to limit the capacity of monocytes to develop into DCs, reduce Ag uptake, upregulate adhesion molecule expression, downregulate maturation markers, such as CD40, CD80, CD86, and MHC class II, inhibit production of proinflammatory cytokines including IL-1a, IL-1b, IL-6, IL-12p70, IFN-g, and TNF-a, reduce Ag presentation via the MHC class II pathway, and downmodulate T cell stimulatory capacity (16)(17)(18)(19)(20)(21)(22).…”